Annelies Vertommen holds a master’s degree in Biology and a Ph.D. in Bioengineering. She started her career at Nelson Labs as Study Director for extractables and leachables projects, gaining experience in the different application fields of the pharmaceutical industry. In recent years, she has focused on chemical characterization studies for the medical device industry. She is a team leader of a group of study directors specialized in the set-up of studies according to ISO 10993-18 in the broader context of ISO 10993-1.
Besides her activities in the field of medical devices, Annelies also leads the group of study directors focusing on compendial testing according to the current US, European and Japanese Pharmacopoeia. With her group, she follows all changes in the regulatory field by interacting with the respective committee members and by attending and presenting at several conferences in the two domains.